High-Dose Intramuscular Triamcinolone in Severe, Chronic, Life-Threatening Asthma
THE majority of patients with asthma have mild symptoms that can be controlled with beta-2 agonists, cromolyn, theophylline, inhaled corticosteroids, or a combination of these agents. Systemic corticosteroids are often required during acute exacerbations. A small percentage of patients, however, hav...
Saved in:
Published in: | The New England journal of medicine Vol. 324; no. 9; pp. 585 - 589 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Boston, MA
Massachusetts Medical Society
28-02-1991
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | THE majority of patients with asthma have mild symptoms that can be controlled with beta-2 agonists, cromolyn, theophylline, inhaled corticosteroids, or a combination of these agents. Systemic corticosteroids are often required during acute exacerbations. A small percentage of patients, however, have severe and even life-threatening asthma. This group is characterized by long-term dependency on steroids, frequent emergency room visits, recurrent hospitalizations, and often a history of requiring mechanical ventilation. Despite treatment with systemic steroids, these patients are forced to modify their lifestyle to adapt to their chronic, disabling shortness of breath. Methotrexate,
1
,
2
gold,
3
,
4
troleandomycin,
5
,
6
and a moderate monthly dose . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM199102283240903 |